Family Smoking Prevention and Tobacco Control Act Regulatory Research
Active
- Assistance listing
- 93.077
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Grant awards
- 372 $1,776,998,868 in federal obligations
Program facts
- Also known as
- NIH-FDA Tobacco Control Regulatory Research
- Assistance types
-
- Cooperative Agreement
- Project Grant
- Treasury account
-
- 75-2018-0-6-000
- More information
Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.
About this program
The Department of Health and Human Services National Institutes of Health is awarding grants under CFDA 93.077, Family Smoking Prevention and Tobacco Control Act Regulatory Research, with the most recent award dated September 1, 2026. This program funds scientific research to guide the FDA's implementation of tobacco product regulation mandated by the Family Smoking Prevention and Tobacco Control Act.
The program funds regulatory science investigating tobacco product manufacturing, distribution, marketing, and health effects. Recent awards span e-cigarette toxicity and abuse liability (synthetic coolants, nicotine forms, flavoring compounds), electronic nicotine delivery system use patterns and cessation outcomes, oral nicotine pouch characteristics and behavioral effects, menthol regulation impacts, cigar and cigarette marketing and packaging features, product composition analysis, and communications research on tobacco product risk messaging. Awards also cover comparative health effects of combustible versus non-combustible products, including cardiovascular and respiratory impacts in dual users, biomarker development, and population-level regulatory impact modeling.
Awards are predominantly Project Grants (256 awards, 69%) with a substantial share of Cooperative Agreements (116 awards, 31%). The NIH Office of the Director dominates funding by dollar volume, obligating $1 billion across 162 awards. The FDA obligated $414.4 million across 136 awards, the second-largest contributor. Combined federal dollars obligated total $1.78 billion across 372 awards since 1975. Recent annual volume has ranged from 5 to 23 awards per year; 2026 shows 8 awards through September.
Recent awards exemplify regulatory-relevant work: e-cigarette use and emphysema development; electronic nicotine delivery systems' cardiopulmonary effects in dual users; synthetic coolant toxicity in e-cigarette aerosols; clinical pharmacology of oral nicotine pouches; nicotine pouch abuse liability; comparative effectiveness of nicotine pouches for cigarette substitution; and misleading tobacco marketing on youth. Award magnitudes range from $234 thousand to $11.8 million, with typical multiyear research projects.
Multiple funding opportunities remain open or recently posted. The Tobacco Centers of Regulatory Science (TCORS) U54 Cooperative Agreement (RFA-OD-28-001) was posted July 2026, soliciting collaborative multidisciplinary centers on addiction, behavior, communications, health effects, impact analysis, marketing, product composition, and toxicity. High-Priority Research in Tobacco Regulatory Science (RFA-OD-25-001, R01) closed June 2025. The R03 Small Grant for New Investigators (RFA-OD-25-008) has a due date of July 14, 2026. K01 Mentored Career Development and K99/R00 Pathway to Independence awards in tobacco regulatory research remain available with March 2025 deadlines. All opportunities require research within FDA Center for Tobacco Products regulatory authority.
Objective and description
- Objective
The Family Smoking Prevention and Tobacco Control Act (TCA) provides the authority to regulate tobacco product manufacturing, distribution and marketing. Regulatory research will provide the scientific evidence to guide the implementation of this aut
Eligibility
- Applicant eligibility
Applicants should review the eligibility information in the individual funding opportunity announcements issued under this CFDA.
- Beneficiary eligibility
This Tobacco Control Regulatory Research Program will support research aimed at providing guidance and evidence to develop regulation for tobacco product manufacturing, distribution and marketing. The general public will ultimately benefit.
- Uses of assistance
(1) Research project grants provide support for clearly defined projects or a small group of related research activities, and when appropriate, support of research conferences; (2) program project and center grants support large-scale, broad-based programs of research, usually interdisciplinary, consisting of several projects with a common focus; (3) exploratory/development and clinical exploratory/developmental grants encourage the development of new research activities in categorical program areas; (4) cooperative agreements support single or a group of related research activities with significant involvement of federal staff; and (5) research training grants including fellowships and institutional training grants, career development grants and loan repayment contracts.
- Length and time phasing of assistance
Award length may vary depending on the recommendation of the scientific review group, the national advisory council, successful annual performance, and availability of funds, with project periods ranging from 1 to 5 years. Funding commitments are made annually.
How to apply
- Preapplication coordination
Preapplication coordination is generally not applicable, though applicants requesting direct costs of $500,000 or more for any one year must contact the appropriate NIH Institute or Center no later than 6 weeks before the anticipated submission date.
- Application procedure
This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. Most applications must be prepared and submitted electronically. Most applicants use the SF 424 (Research & Related) for electronic submission. Information about the SF 424 form may be found on http://grants.nih.gov/grants/funding/424/index.htm, but application packages should be accessed through the appropriate funding opportunity announcement, found either on the NIH Guide to Grants and Contracts (http://grants1.nih.gov/grants/guide/index.html) or through the Grants.gov website (http://www.grants.gov/). Some institutions may submit the grant data directly (using what is called a system-to-system transfer). For further details, see grants.gov or eRA Commons. The timeline for transition to electronic applications and the new forms may be found at: http://era.nih.gov/ElectronicReceipt/. For further assistance contact GrantsInfo, Telephone (301) 435-0714, Email: GrantsInfo@nih.gov. Consultation on a proposed project may be obtained from the Office of Disease Prevention in the Division of Program Coordination, Planning, and Strategic Initiatives at NIH. Applications are reviewed by principally nonfederal consultants recruited nationwide. The amounts of the award and period of support are determined on the basis of merit of the project and the nature of the grant mechanism. Electronic applications are submitted through the Grants.gov website.
- Criteria for selecting proposals
Funding decisions are based on scientific merit (42 CFR 52h) and program relevance. Scientific merit review encompasses: the peer review criteria detailed in the specific funding announcement, as well as the significance, approach, and innovation of the proposed research; the competency of the principal investigator; the adequacy of the resources and environment; the proposed budget and requested period of support; and, where applicable, the adequacy of the measures for protecting against adverse effects upon humans, animals, or the environment. Relevance to Tobacco Control Regulatory Research program priorities will also be taken into consideration.
- Award procedure
All applications for research grants, cooperative agreements, and training grants are evaluated for scientific and technical merit by an appropriate scientific peer review panel and by the National Advisory Council of the NIH Institute or Center that will manage the award. All competitive applications compete for available funds on the basis of scientific and technical merit, program relevance, and program balance. FDA Center for Tobacco Control will make final decisions on the relevance and program balance.
- Time to approval or disapproval
Review the individual Funding Opportunity Announcement under this CFDA for any application-specific deadlines.
- Renewals
Renewal grants may only be submitted in response to a specific funding opportunity announcement under this CFDA.
- Appeals
A principal investigator may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is available on the NIH homepage http://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-064.html.
Grant opportunities
Show 40 more
Latest 50 listed here. See the rest on GovTribe.
Grant awards
Latest 10 of 372 listed here. See the rest on GovTribe.
Top recipients by federal obligations
| Rank | Recipient | Federal obligations | Share |
|---|---|---|---|
| 1 | Regents Of The University Of Michigan | $233,047,826 | 13% |
| 2 | Yale Univ | $117,289,610 | 7% |
| 3 | University Of North Carolina At Chapel Hill | $109,422,231 | 6% |
| 4 | University Of Southern California | $109,336,035 | 6% |
| 5 | Wake Forest University Health Sciences | $84,229,495 | 5% |
| 6 | The Ohio State University | $75,965,522 | 4% |
| 7 | The Regents Of The University Of California. San Francisco | $72,934,053 | 4% |
| 8 | The Trustees Of The University Of Pennsylvania | $70,224,121 | 4% |
| 9 | Westat, Inc. | $69,291,833 | 4% |
| 10 | Pennsylvania State University | $59,109,630 | 3% |
10 of 129 recipients listed here. See the rest on GovTribe.
Federal obligations by fiscal year
| Fiscal year | Federal obligations |
|---|---|
| FY2026 | $32,465,802 |
| FY2025 | $114,865,586 |
| FY2024 | $185,145,536 |
| FY2023 | $136,973,894 |
| FY2022 | $181,494,929 |
| FY2021 | $148,845,834 |
| FY2020 | $114,110,111 |
| FY2019 | $71,238,697 |
| FY2018 | $72,765,922 |
| FY2017 | $90,229,651 |
| FY2016 | $96,574,057 |
| FY2015 | $111,747,673 |
| FY2014 | $101,097,409 |
| FY2013 | $97,617,462 |
| FY2012 | $22,347,574 |
Show all 15
Quick answers
What is Assistance Listing 93.077?
Assistance Listing 93.077 is Family Smoking Prevention and Tobacco Control Act Regulatory Research, a federal grant program run by National Institutes of Health (Department of Health and Human Services).
What is the CFDA number for Family Smoking Prevention and Tobacco Control Act Regulatory Research?
Its CFDA number is 93.077: Assistance Listing numbers were called CFDA numbers before 2018.
How much funding has Assistance Listing 93.077 awarded?
372 grant awards under 93.077 have obligated $1,776,998,868 in federal funds to 129 recipients.
Who receives the most funding from 93.077?
The recipients obligated the most under Family Smoking Prevention and Tobacco Control Act Regulatory Research are Regents Of The University Of Michigan ($233,047,826), Yale Univ ($117,289,610) and University Of North Carolina At Chapel Hill ($109,422,231).
How much did 93.077 obligate in fiscal year 2025?
Grants under 93.077 obligated $114,865,586 in federal funds in fiscal year 2025.
Are there open grant opportunities under 93.077?
1 of the latest 50 opportunities under 93.077 is open or forecasted. The latest, Tobacco Centers of Regulatory Science (TCORS) (Clinical Trial Optional), was posted on July 9, 2026.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program